Renoprotective effects of montelukast, a cysteinyl leukotriene receptor antagonist, against methotrexate-induced kidney damage in rats

By Abdel-Raheem Ihab   Khedr Naglaa  

Naunyn-Schmiedeberg's Archives of Pharmacology, Vol. 387, Iss. 4, 2014-04 ,pp. : 341-353

Springer Publishing Company

Access to resources Recommend Favorite

CysLTR1 promoter polymorphism and requirement for leukotriene receptor antagonist in aspirin-intolerant asthma patients

By Kim Seung-Hyun   Ye Young-Min   Hur Gyu Young   Lee Soo-Keol   Sampson Anthony P   Lee Hyun-Young   Park Hae-Sim  

Pharmacogenomics, Vol. 8, Iss. 9, 2007-09 ,pp. : 1143-1150

Future Medicine

Access to resources Recommend Favorite

Treatment of Allergic Rhinitis in Infants and Children: Efficacy and Safety of Second-Generation Antihistamines and the Leukotriene Receptor Antagonist Montelukast

By Phan Hanna  

Drugs, Vol. 69, Iss. 18, 2009-12 ,pp. : 2541-2576

Adis International

Access to resources Recommend Favorite

Discriminative stimulus effects of the cannabinoid CB₁ receptor antagonist rimonabant in rats

By Järbe Torbjörn   Li Chen   Vadivel Subramanian   Makriyannis Alexandros  

Psychopharmacology, Vol. 198, Iss. 4, 2008-07 ,pp. : 467-478

Springer Publishing Company

Access to resources Recommend Favorite

Pharmacological profile of MEN91507, a new CysLT 1 receptor antagonist

By Cabre F.   Carabaza A.   Garca A.M.   Calvo L.   Cucchi P.   Palomer A.   Pascual J.   Garca M.L.   Manzini S.   Lecci A.   Crea A.   Maggi C.A.  

European Journal of Pharmacology, Vol. 451, Iss. 3, 2002-09 ,pp. : 317-326

Elsevier

Access to resources Recommend Favorite